CLINICAL_TRIALS
trial_result
· 2025-08-22
Clinical Trial Update: A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia [Phase 2]
Summary
This clinical trial update reports the completion of a Phase 2 study of Vatiquinone for Friedreich's ataxia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED